Advertisement
Letter to the Editor| Volume 58, ISSUE 3, P323, November 20, 2007

Bisphosphonate use and prevalence of breast arterial calcification on mammography

      We read with great interest the article by Schnatz et al. [
      • Schnatz P.F.
      • Rotter M.A.
      • Hadley S.
      • et al.
      Hormonal therapy is associated with a lower prevalence of breast arterial calcification on mammography.
      ] in which they showed that hormonal therapy is associated with a lower prevalence of breast arterial calcification (BAC) on mammography while well-established risk factors (diabetes, stroke, and age) appear to be associated with significantly higher incidence of BAC. However, history of bisphosphonate use may also influence prevalence of BAC on these patients. Bisphosphonates are the first-line drugs for treating postmenopausal women with osteoporosis. Alendronate and risedronate reduce the risk of both vertebral and nonvertebral fractures. We previously suggest that bisphosphonate use for osteoporosis in postmenopausal women may inhibit occurrence of malignant microcalcification in breast tissue and development of atherosclerosis formation through its bactericidal effect on nanobacteria [
      • Altundag K.
      • Silay Y.S.
      • Altundag O.
      • et al.
      Bisphosphonate use for osteoporosis in postmenopausal women may inhibit occurrence of malignant microcalcification in breast tissue.
      ,
      • Silay Y.S.
      • Altundag K.
      • Altundag O.
      • et al.
      Bisphosphonates may inhibit development of atherosclerosis formation through its bactericidal effect on nanobacteria.
      ]. In the light of above information bisphosphonate use may also lead to lower prevalence of BAC on mammography.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Maturitas
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Schnatz P.F.
        • Rotter M.A.
        • Hadley S.
        • et al.
        Hormonal therapy is associated with a lower prevalence of breast arterial calcification on mammography.
        Maturitas. 2007; ([Epub ahead of print])
        • Altundag K.
        • Silay Y.S.
        • Altundag O.
        • et al.
        Bisphosphonate use for osteoporosis in postmenopausal women may inhibit occurrence of malignant microcalcification in breast tissue.
        Med Hypotheses. 2006; 67: 202-203
        • Silay Y.S.
        • Altundag K.
        • Altundag O.
        • et al.
        Bisphosphonates may inhibit development of atherosclerosis formation through its bactericidal effect on nanobacteria.
        Med Hypotheses. 2005; 64: 1239-1240